drugset / Trial / NCT06714825
Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics in Overweight/Obese Healthy Subjects
RandomizedSequentialQuadruple-blindBasic science
Summary
Study of HS235 for Assessing the Pharmacokinetics, Safety, and Pharmacodynamics of HS235 in Overweight and Obese Otherwise Healthy Subjects
Timeline
- Start
- 2024-11-28
- Primary completion
- 2025-12-02
- Completion
- 2025-12-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HS235 | Unknown | — | Subcutaneous |
Indications
No indication recorded.